Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development
Therapeutic Advances in Cardiovascular Disease · 2024-01 · 18
DOI: 10.1177/17539447241253134 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 31.05.2024. Verfasst von Amirreza Khalaji und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5166/15731, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Fibrosis, Signal Transduction. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cardiac fibrosis is a pivotal cardiovascular disease (CVD) process and represents a notable health concern worldwide. While the complex mechanisms underlying CVD have been widely investigated, recent research has highlighted microRNA-21’s (miR-21) role in cardiac fibrosis pathogenesis. In this narrative review, we explore the molecular interactions, focusing on the role of miR-21 in contributing to cardiac fibrosis. Various signaling pathways, such as the RAAS, TGF-β, IL-6, IL-1, ERK, PI3K-Akt, and PTEN pathways, besides dysregulation in fibroblast activity, matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs cause cardiac fibrosis. Besides, miR-21 in growth factor secretion, apoptosis, and endothelial-to-mesenchymal transition play crucial roles. miR-21 capacity regulatory function presents promising insights for cardiac fibrosis. Moreover, this review discusses numerous approaches to control miR-21 expression, including antisense oligonucleotides, anti-miR-21 compounds, and Notch signaling modulation, all novel methods of cardiac fibrosis inhibition. In summary, this narrative review aims to assess the molecular mechanisms of cardiac fibrosis and its essential miR-21 function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5166/15731, Iran.
- Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Faculty of Medicine, Islamic Azad University of Ardabil, Ardabil, Iran.
- Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Department of Oncology and Hematology, University of Chicago, Chicago, IL, USA.
ORCID-Profile: Amirreza Khalaji
Zitieren
APA
Khalaji, A., Mehrtabar, S., Jabraeilipour, A., Doustar, N., Rahmani Youshanlouei, H., Tahavvori, A., Fattahi, P., Alavi, S. M. A., Taha, S. R., Fazlollahpour-Naghibi, A., & Shariat Zadeh, M. (2024). Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development. Therapeutic Advances in Cardiovascular Disease, 18. https://doi.org/10.1177/17539447241253134
Vancouver
Khalaji A, Mehrtabar S, Jabraeilipour A, Doustar N, Rahmani Youshanlouei H, Tahavvori A, et al. Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development. Therapeutic Advances in Cardiovascular Disease. 2024;18. doi:10.1177/17539447241253134
BibTeX
@article{Khalaji2024,
author = {Khalaji, Amirreza and Mehrtabar, Saba and Jabraeilipour, Armin and Doustar, Nadia and Rahmani Youshanlouei, Hamed and Tahavvori, Amir and Fattahi, Payam and Alavi, Seyed Mohammad Amin and Taha, Seyed Reza and Fazlollahpour-Naghibi, Andarz and Shariat Zadeh, Mahdieh},
title = {Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2024},
volume = {18},
doi = {10.1177/17539447241253134}
}
EUVIMED